NEUROTECH INTERNATIONAL LIMITED
ASX
AU Flag
NTI

NTI
NEUROTECH INTERNATIONAL LIMITED
AU Flag
ASX
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

NTI Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Employees: ---
Neurotech International Limited (Neurotech) is an Australia-based medical device and solutions company. The Company is focused on developing neuro-stimulation and neuro-diagnostic solutions. The Company delivers its solutions through the mente platform, a platform technology to enable medical practitioners to remotely monitor and play an active role in home-based therapies. Its product, Mente Autism, assists with the management of children with Autism Spectrum Disorder (ASD). Mente Autism is an electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to help relax the minds of children with ASD. It has a pipeline of products, which are split between the business-to-consumer (B2C) or end user/consumer family of products for home-use, such as Neurotech first product, Mente Autism, and the business-tobusiness (B2B) or business-focused family of products for clinical use. It operates through its subsidiary, AAT Research.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out